Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Darren Peress

Clinical Cardiac Electrophysiology Tucson, AZ Medical Doctor

NPI 1548248057 CMS profile 341955

4729 E Camp Lowell Dr, Tucson, AZ 85712

Open in the dashboard

General payments

$18,553

877 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$293,932 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Darren Peress of Tucson, AZ is reported in the CMS Open Payments database as having received $18,553 across 877 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $293,932 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 50th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,076 120
2024 General $1,552 78
2023 General $3,224 158
2022 General $4,298 170
2021 General $2,927 109
2020 General $1,442 117
2019 General $3,036 125

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Darren Peress
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Darren Peress were reported at $2,076. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Darren Peress Clinical Cardiac Electrophysiology median Middle half National median
2019 $3,036 $2,361 $585–$8,260 $163
2020 $1,442 $993 $247–$4,351 $114
2021 $2,927 $1,185 $326–$4,739 $132
2022 $4,298 $2,073 $554–$6,789 $149
2023 $3,224 $2,568 $759–$8,159 $160
2024 $1,552 $2,557 $703–$7,403 $164
2025 $2,076 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $4,171 312 payments
  2. Biosense Webster, Inc. $4,010 116 payments
  3. Abbott Laboratories $2,157 114 payments
  4. Philips Electronics North America Corporation $1,628 8 payments
  5. Novartis Pharmaceuticals Corporation $1,132 170 payments
  6. Medical Device Business Services, Inc. $831 3 payments
  7. Atricure, Inc. $596 6 payments
  8. Pfizer Inc. $392 12 payments
  9. E.R. Squibb & Sons, L.L.C. $388 12 payments
  10. Impulse Dynamics (USA) Inc. $379 8 payments
  11. Other $2,869 116 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $13,631 866 payments
  2. Consulting Fee $3,600 4 payments
  3. Travel and Lodging $1,177 5 payments
  4. Education $79 1 payment
  5. Debt forgiveness $66 1 payment
Products named General payments · program years 2019–2025
  1. Carto 3 $3,978 91 payments
  2. CVX-300 $1,500 1 payment
  3. ENTRESTO $571 101 payments
  4. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $462 5 payments
  5. General - Therapies $454 24 payments
  6. General Therapies $371 24 payments
  7. LifeVest $367 20 payments
  8. CardioMEMS HF System $321 12 payments
  9. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $297 16 payments
  10. Optimizer $285 6 payments
  11. Other $8,252 514 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 27 drugs

Part D claims

1,680

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$989,237

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

42.1%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 427 $583,508
Camzyos Mavacamten Brand 20 $167,721
Entresto Sacubitril/Valsartan Brand 86 $135,239
Xarelto Rivaroxaban Brand 36 $54,666
Farxiga Dapagliflozin Propanediol Brand 14 $22,893
Flecainide Acetate Generic 111 $7,360
Dofetilide Generic 19 $3,685
Digoxin Generic 82 $3,011
Amiodarone Hcl Generic 65 $1,875
Sotalol Sotalol Hcl Brand 72 $1,807

The 10 drugs with the highest cost, of 27 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 89 billing codes

Paid by Medicare

$330,886

Of which drugs: $299

Medicare patients

1,907

Average age 77

Services billed

7,667

934 women, 973 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 53%
Arthritis 52%
Ischemic heart disease 50%
Heart failure 40%
Chronic kidney disease 38%
Diabetes 33%
Depression 29%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 41 2,880 $299

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
VYNDAQEL
$42 — —
ELIQUIS
$15 427 —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

877 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record